Лечение больных раком мочевого пузыря в стадии Т1G3

1. Herr H.W., Jakse G., Sheinfeld J. The T1 bladder tumor. Semin Urol 1990; 8: 254.

2. Holmang S., Hedelin H., Anderstrom C. et al. The importance of the depth of invasion in stage T1 bladder carcinoma: A prospective cohort study. J Urol 1997; 157: 800.

3. Hurle R., Losa A., Ranieri A. et al. Intravesical bacillus Calmette-Guerin in stage T1, grade 3 bladder cancer therapy: a 7-year follow-up. Urology 1999; 54: 258–63.

4. Cheng L., Weaver A.L., Neumann R.M. et al. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999; 86: 1035.

5. Shahin O., Thalmann G.N., Rentsch C. et al. A retrospective analysis of 153 patients treated with or without intravesical BCG for primary stage T1 grade G3 bladder cancer: recurrence, progression, survival. J Urol 2003; 169: 96–100.

6. Heney N.M., Ahmed S., Flanagan M.J. et al. National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083.

7. Jakse G., Loidl W., Seeber G., Hofstadter F. Stage T1, grade 3 transitional carcinoma of the bladder: an unfavourable tumour. J Urol 1984;137:39–43.

8. Kaubisch S., Lum B.L., Reese J. et al. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 1991; 146: 28–31.

9. Lutzeyer W., Rübben H., Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127: 250–2.

10. Baniel J., Grauss D., Engelstein D. et al. Intravesical bacillus treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder. Urology 1998; 52: 785–9.

11. Brake M., Loertzer H., Horsch R. et al. Reccurence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 2000; 163: 1697–701.

12. Gohji K., Nomi M., Okamoto M. et al. Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 1999; 53: 308.

13. Klän R., Steiner U., Sauter T. et al: Zystektomie beim schlecht differenzierten T1-Harnblasenkarzinom—oft zu früh? Akt Urol 1998; 29: 53.

14. Lebret T., Gaudez F., Herve J.M. et al. Low-dose BCG instillations in the treatment of Stage T1 Grade 3 bladder tumors: recurrence, progression and success. Eur Urol 1998; 34: 67–72.

15. Pansadoro V., Emiliozzi P., De Paula F. et al. Long-term follow-up of T1G3 Transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology 2002; 59: 227–31.

16. Oosterlinck W., Lobel B., Jakse G. et al. The EAU Working group on Oncological Urology. European Association of Urology Guidelines on bladder cancer. Eur Urol 2002; 41: 105–12.

17. Cookson M.S, Herr H.W., Zhang Z.F. et al. The treated natural history of high risk superficial bladder cancer: 15-year out-come. J Urol 1997; 158: 62–7.